User: Guest

LUNG CANCER THERAPEUTICS

Global Market Trajectory & Analytics

MCP-1873

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

8086
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1132
Interactions with Platform & by Email

PARTICIPANTS

243
Unique # Participated

VALIDATIONS

109
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JULY 2020

TABLES

108

PAGES

329

EDITION

16

PRICE

USD $5450


Amid the COVID-19 crisis, the global market for Lung Cancer Therapeutics estimated at US$20.4 Billion in the year 2020, is projected to reach a revised size of US$44.4 Billion by 2027, growing at aCAGR of 11.7% over the period 2020-2027. Non-Small-Cell Lung Cancer (NSCLC), one of the segments analyzed in the report, is projected to record 12.9% CAGR and reach US$30 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Small-Cell Lung Cancer (SCLC) segment is readjusted to a revised 9.6% CAGR for the next 7-year period.
The Lung Cancer Therapeutics market in the U.S. is estimated at US$5.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.8 Billion by the year 2027 trailing a CAGR of 15.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 10.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.We bring years of research experience to this 16th edition of our report. The 329-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Bristol-Myers Squibb Company; F. Hoffmann-La Roche AG; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.
» Type (Non-Small-Cell Lung Cancer (NSCLC), and Small-Cell Lung Cancer (SCLC))
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Global Competitor Market Shares
Lung Cancer Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Lung Cancer Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Lung Cancer Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
Lung Cancer Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Non-Small-Cell Lung Cancer (NSCLC) (Type) World Market by Region/Country in US$ Million: 2018 to 2025
Non-Small-Cell Lung Cancer (NSCLC) (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Non-Small-Cell Lung Cancer (NSCLC) (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Small-Cell Lung Cancer (SCLC) (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
Small-Cell Lung Cancer (SCLC) (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
Small-Cell Lung Cancer (SCLC) (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
United States
Market Facts & Figures
US Lung Cancer Therapeutics Market Share (in %) by Company: 2019 & 2025
United States Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
Lung Cancer Therapeutics Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
United States Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Canada
Canadian Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
Canadian Lung Cancer Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
Lung Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
Japan
Japanese Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
Lung Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
Japanese Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
China
Chinese Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
Lung Cancer Therapeutics Historic Market Analysis in China in US$ Million by Type: 2009-2017
Chinese Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Europe
Market Facts & Figures
European Lung Cancer Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Lung Cancer Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
Lung Cancer Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European Lung Cancer Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
Lung Cancer Therapeutics Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
European Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
France
Lung Cancer Therapeutics Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
French Lung Cancer Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
French Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
Germany
Lung Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
German Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
German Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Italy
Italian Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
Lung Cancer Therapeutics Historic Market Analysis in Italy in US$ Million by Type: 2009-2017
Italian Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Kingdom
United Kingdom Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
Lung Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
United Kingdom Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
Spain
Spanish Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
Spanish Lung Cancer Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
Lung Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
Russia
Russian Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
Lung Cancer Therapeutics Market in Russia by Type: A Historic Review in US$ Million for 2009-2017
Russian Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Rest of Europe
Rest of Europe Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
Lung Cancer Therapeutics Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
Rest of Europe Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Asia-Pacific
Asia-Pacific Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Lung Cancer Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
Asia-Pacific Lung Cancer Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
Lung Cancer Therapeutics Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Lung Cancer Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
Asia-Pacific Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
Australia
Lung Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
Australian Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
Australian Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
India
Indian Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
Indian Lung Cancer Therapeutics Historic Market Review by Type in US$ Million: 2009-2017
Lung Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
South Korea
Lung Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
South Korean Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
Lung Cancer Therapeutics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
Rest of Asia-Pacific
Rest of Asia-Pacific Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
Lung Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
Rest of Asia-Pacific Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
Latin America
Latin American Lung Cancer Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025
Lung Cancer Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
Latin American Lung Cancer Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Latin American Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
Lung Cancer Therapeutics Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017
Latin American Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Argentina
Argentinean Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
Lung Cancer Therapeutics Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017
Argentinean Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Brazil
Lung Cancer Therapeutics Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025
Brazilian Lung Cancer Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017
Brazilian Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
Mexico
Lung Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
Mexican Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
Mexican Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Rest of Latin America
Rest of Latin America Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
Lung Cancer Therapeutics Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017
Rest of Latin America Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Middle East
The Middle East Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Lung Cancer Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017
The Middle East Lung Cancer Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
The Middle East Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
The Middle East Lung Cancer Therapeutics Historic Market by Type in US$ Million: 2009-2017
Lung Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
Iran
Iranian Market for Lung Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
Lung Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
Iranian Lung Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
Israel
Israeli Lung Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025
Lung Cancer Therapeutics Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017
Israeli Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Saudi Arabia
Saudi Arabian Lung Cancer Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025
Lung Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017
Saudi Arabian Lung Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Arab Emirates
Lung Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
United Arab Emirates Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
Lung Cancer Therapeutics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
Rest of Middle East
Lung Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
Rest of Middle East Lung Cancer Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017
Rest of Middle East Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Africa
African Lung Cancer Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025
Lung Cancer Therapeutics Market in Africa by Type: A Historic Review in US$ Million for 2009-2017
African Lung Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
Total Companies Profiled : 43

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

General queries: Info411@StrategyR.com